Cytek Biosciences, Inc. - Common Stock — Cash Flow (NASDAQ:CTKB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 4.63 M-12.23 M5.28 M25.38 M-4.69 M -7.3 M Cash from investing activities -20.99 M-55.91 M-93.89 M-82.97 M10.12 M -26.41 M Cash from financing activities 213.56 M5.51 M-41.81 M-15.82 M-13.43 M 2.09 M Free cash flow 4.63 M-12.23 M5.28 M25.38 M-4.69 M -7.3 M

News

Cytek Biosciences, Inc. (CTKB) Presents at Singular Research's Las Vegas Invitational Conference - Slideshow (NASDAQ:CTKB) 2026-06-15

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates

Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:CTKB) 2026-01-15

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat (NASDAQ:BYND), Avadel Pharmaceuticals (NASDAQ:AVDL)

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates